Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.3963
-0.0357 (-8.26%)
At close: Sep 16, 2025, 4:00 PM EDT
0.4014
+0.0051 (1.29%)
After-hours: Sep 16, 2025, 6:39 PM EDT
RVPH Market Cap
RVPH has a market cap or net worth of $26.95 million as of September 16, 2025. Its market cap has decreased by -19.37% in one year.
Market Cap
26.95M
Enterprise Value
18.95M
1-Year Change
-19.37%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $26.95M, an increase of 6.90%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 29.38M | -65.15% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | 80.73M | 195.66% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |